<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
  <url><loc>https://gosset.ai/news</loc><lastmod>2026-11-15</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-15</loc><lastmod>2026-11-15</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-15/mazdutide-gains-china-reimbursement-a8acbc1a</loc><lastmod>2026-11-15</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-15/ojemda-four-year-firefly-1-results-edef3c76</loc><lastmod>2026-11-15</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-14</loc><lastmod>2026-11-14</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-14/henlius-achieves-full-reimbursement-coverage-6c677024</loc><lastmod>2026-11-14</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-14/ak111-wins-second-approval-b25acf05</loc><lastmod>2026-11-14</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-14/windward-bio-lists-on-nasdaq-d25723a7</loc><lastmod>2026-11-14</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-14/kelun-adcs-gain-reimbursement-02b7f73b</loc><lastmod>2026-11-14</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-14/tong-ren-tang-acquisition-e76c903e</loc><lastmod>2026-11-14</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-13</loc><lastmod>2026-11-13</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-13/mexico-approves-restylane-shaype-f8d82938</loc><lastmod>2026-11-13</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-13/positive-eu-opinion-for-welireg-63ca03d7</loc><lastmod>2026-11-13</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-13/tong-ren-tang-plans-acquisition-7783322e</loc><lastmod>2026-11-13</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-13/arrowhead-reports-fiscal-2026-results-a1a02191</loc><lastmod>2026-11-13</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-13/sinovent-drug-approved-1e635724</loc><lastmod>2026-11-13</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-12</loc><lastmod>2026-11-12</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-12/hengrui-wins-china-approval-for-shr-1918-first-local-angptl3-antibody-in-d5ccb936</loc><lastmod>2026-11-12</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-12/china-approves-eravacycline-100-mg-75db797c</loc><lastmod>2026-11-12</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-12/vor-bio-adds-remegens-long-acting-baff-april-blocker-rc298-to-its-3e69831f</loc><lastmod>2026-11-12</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-12/novartiss-rhapsido-keeps-working-through-one-year-in-chronic-inducible-44ab51e2</loc><lastmod>2026-11-12</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-12/china-approves-lillys-orforglipron-its-first-oral-glp-1-pill-for-weight-900a3944</loc><lastmod>2026-11-12</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-12/elafibranor-normalizes-alp-in-most-pbc-patients-in-phase-3-elspire-d50eb2ba</loc><lastmod>2026-11-12</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-12/engene-to-start-detalimogene-bla-by-year-end-after-new-legend-bladder-4dbb0240</loc><lastmod>2026-11-12</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-12/blackstone-commits-up-to-1-5-billion-toward-pfizers-monthly-glp-1-7e120f18</loc><lastmod>2026-11-12</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-12/innovent-gastric-cancer-data-e2445018</loc><lastmod>2026-11-12</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-12/dbv-presents-further-vitesse-phase-3-results-for-viaskin-peanut-patch-in-8c413096</loc><lastmod>2026-11-12</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-11</loc><lastmod>2026-11-11</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-11/astrazeneca-buys-bacterial-vaccine-biotech-omniose-after-research-tie-up-6072d393</loc><lastmod>2026-11-11</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-11/fda-clears-abbiskos-pimicotinib-sold-by-merck-kgaa-for-tenosynovial-0c4b2074</loc><lastmod>2026-11-11</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-11/fda-adds-rare-optic-nerve-risk-to-warnings-for-all-glp-1-drugs-54329722</loc><lastmod>2026-11-11</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-11/lillys-taltz-plus-zepbound-beats-taltz-alone-at-one-year-in-obese-b41f8ed3</loc><lastmod>2026-11-11</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-11/amgens-dazodalibep-cuts-sjogrens-disease-activity-in-phase-3-oasiz-301-7dbcbba1</loc><lastmod>2026-11-11</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-11/brightgenes-bgm0504-meets-goals-in-two-chinese-phase-3-type-2-diabetes-b4a00dcb</loc><lastmod>2026-11-11</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-11/beams-base-edited-risto-cel-hits-main-goal-in-sickle-cell-study-bla-eyed-da5b74ef</loc><lastmod>2026-11-11</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-11/vectory-therapeutics-secures-eur-74-5-million-for-vectorized-antibody-775b17ff</loc><lastmod>2026-11-11</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-11/bms-reports-56-week-scout-hcm-data-for-mavacamten-in-adolescents-with-9c5d2ebb</loc><lastmod>2026-11-11</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-11/pepgen-launches-125-million-stock-offering-to-fund-clinical-programs-ac7f2e3f</loc><lastmod>2026-11-11</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-10</loc><lastmod>2026-11-10</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-10/fda-approves-bayers-asundexian-the-first-factor-xia-inhibitor-to-prevent-022ec78a</loc><lastmod>2026-11-10</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-10/alnylams-five-year-helios-b-data-favor-starting-vutrisiran-early-in-attr-392a46e4</loc><lastmod>2026-11-10</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-10/novartis-reports-two-year-ianalumab-data-showing-deeper-control-of-da787759</loc><lastmod>2026-11-10</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-10/abbvie-licenses-nxeras-oral-ep4-agonist-for-ibd-for-up-to-1-47-billion-ff02093f</loc><lastmod>2026-11-10</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-10/j-and-js-caplyta-succeeds-in-second-phase-3-trial-in-bipolar-i-mania-ec53271a</loc><lastmod>2026-11-10</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-10/bahrain-approves-gan-and-lees-insulin-glargine-prefilled-pen-9f087e36</loc><lastmod>2026-11-10</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-10/chinas-cde-proposes-breakthrough-status-for-lepus-cdh17-adc-mrg007-in-df202189</loc><lastmod>2026-11-10</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-10/delix-raises-100-million-series-c-to-move-zalsupindole-into-phase-iib-949e7885</loc><lastmod>2026-11-10</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-10/kesmalea-becomes-oyster-therapeutics-and-raises-60-million-for-tau-ada128ab</loc><lastmod>2026-11-10</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-10/psithera-raises-25-million-for-oral-immunology-drugs-with-abbvie-0587fc16</loc><lastmod>2026-11-10</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-09</loc><lastmod>2026-11-09</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-09/mentari-closes-inmed-merger-and-490-million-financing-lists-on-nasdaq-as-10fc5f57</loc><lastmod>2026-11-09</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-09/brazil-clears-henlius-hlx11-its-first-pertuzumab-biosimilar-for-her2-a224aa3c</loc><lastmod>2026-11-09</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-09/innovents-tafolecimab-lowers-ldl-c-about-65-pct-as-first-line-a6d68778</loc><lastmod>2026-11-09</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-09/ucbs-bimekizumab-keeps-its-edge-over-risankizumab-in-psoriatic-arthritis-94377bbb</loc><lastmod>2026-11-09</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-09/beijing-fuyuan-gets-chinese-nod-for-generic-extended-release-055e4686</loc><lastmod>2026-11-09</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-09/roches-satralizumab-keeps-most-thyroid-eye-disease-responders-through-13d2cab9</loc><lastmod>2026-11-09</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-09/kanghong-pharmaceutical-gets-chinese-marketing-approval-for-ibrutinib-65c6bddd</loc><lastmod>2026-11-09</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-09/israel-approves-immunitybios-anktiva-with-bcg-for-bcg-unresponsive-093ff1f1</loc><lastmod>2026-11-09</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-09/cormedix-agrees-to-buy-almost-all-heron-assets-adding-four-marketed-071a9ecb</loc><lastmod>2026-11-09</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-09/argenx-to-acquire-peptide-firm-unnatural-products-in-deal-worth-up-to-1-6b26b012</loc><lastmod>2026-11-09</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-08</loc><lastmod>2026-11-08</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-08/novartis-pelacarsen-cuts-lp-a-by-78-pct-but-fails-to-reduce-heart-events-77b9c70e</loc><lastmod>2026-11-08</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-08/allergan-aesthetics-reports-facial-satisfaction-gains-in-glp-1-users-a2c56839</loc><lastmod>2026-11-08</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-08/j-and-js-dual-bispecific-regimen-lowers-psa-in-most-treated-prostate-4844514a</loc><lastmod>2026-11-08</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-08/single-dose-of-cideb-sirna-cuts-liver-fat-up-to-80-pct-in-masld-trial-fe817b57</loc><lastmod>2026-11-08</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-08/gsks-bepirovirsen-cure-holds-for-most-patients-a-year-after-stopping-ff5bc685</loc><lastmod>2026-11-08</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-08/brii-picks-hepatitis-b-cure-regimen-for-registration-study-after-phase-8bdc051a</loc><lastmod>2026-11-08</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-08/bcma-t-cell-engager-velinotamig-shows-early-activity-in-refractory-lupus-967c2e88</loc><lastmod>2026-11-08</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-08/ausperbios-ahb-137-keeps-hepatitis-b-functional-cure-15-months-off-9429691e</loc><lastmod>2026-11-08</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-08/cabalettas-rese-cel-keeps-autoimmune-patients-off-immunomodulators-for-a-39a868d3</loc><lastmod>2026-11-08</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-07</loc><lastmod>2026-11-07</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-07/oral-icotyde-hits-phase-3-goal-in-biologic-naive-psoriatic-arthritis-b2f560bb</loc><lastmod>2026-11-07</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-07/bayer-reports-chinese-subgroup-data-for-asundexian-in-stroke-prevention-febea712</loc><lastmod>2026-11-07</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-07/j-and-j-details-patient-priorities-and-saliva-data-for-nipocalimab-in-ad6245fc</loc><lastmod>2026-11-07</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-07/merck-drops-il-2-agonist-mk-1484-from-its-pipeline-07547add</loc><lastmod>2026-11-07</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-07/novo-links-wegovy-to-liver-and-weight-gains-in-real-world-mash-studies-943928bd</loc><lastmod>2026-11-07</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-07/argenxs-vyvgart-hytrulo-succeeds-in-phase-3-autoimmune-myositis-trial-e2fbc751</loc><lastmod>2026-11-07</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-07/china-accepts-zepuxitini-filing-in-rheumatoid-arthritis-9eba4e1a</loc><lastmod>2026-11-07</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-06</loc><lastmod>2026-11-06</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-06/pfizers-hympavzi-approved-in-china-for-hemophilia-patients-with-52250617</loc><lastmod>2026-11-06</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-06/fda-grants-accelerated-approval-to-subcutaneous-amivantamab-in-head-and-cdd86440</loc><lastmod>2026-11-06</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-06/eu-adds-axial-spondyloarthritis-to-alfasigmas-jyseleca-label-7d4b60c4</loc><lastmod>2026-11-06</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-06/uk-extends-joenja-to-apds-patients-as-young-as-four-84a99345</loc><lastmod>2026-11-06</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-06/funnel-biosciences-signs-ai-antibody-pact-with-third-rock-worth-up-to-2-3c143c9a</loc><lastmod>2026-11-06</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-06/seladelpar-normalizes-alp-in-most-pbc-patients-in-phase-3-ideal-trial-4dca79f6</loc><lastmod>2026-11-06</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-06/china-approves-bayers-her2-inhibitor-for-first-line-her2-mutant-lung-7b6a2326</loc><lastmod>2026-11-06</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-06/tq-b3139-keeps-pfs-lead-over-crizotinib-in-final-alk-positive-lung-cb312431</loc><lastmod>2026-11-06</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-06/inovio-prices-a-75-million-stock-and-warrant-offering-bbfc57c2</loc><lastmod>2026-11-06</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-06/evaxions-evx-01-cancer-vaccine-shows-broad-t-cell-responses-in-phase-2-13767caa</loc><lastmod>2026-11-06</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-05</loc><lastmod>2026-11-05</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-05/orelabrutinib-hits-primary-goal-in-chinese-phase-3-study-in-chronic-itp-26214e1b</loc><lastmod>2026-11-05</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-05/qyuns-licenses-a-second-tl1a-bispecific-to-caldera-this-time-paired-with-eb59ac7b</loc><lastmod>2026-11-05</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-05/china-clears-immunochinas-cd19-car-t-im19-for-relapsed-large-b-cell-6ed4edd5</loc><lastmod>2026-11-05</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-05/ani-pharmaceuticals-bids-about-560m-for-rare-disease-drugmaker-egetis-aeb21dbd</loc><lastmod>2026-11-05</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-05/cbt-001-eye-drop-meets-both-primary-goals-in-phase-3-pterygium-study-82b593e8</loc><lastmod>2026-11-05</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-05/boehringer-pays-358m-upfront-for-options-on-six-sino-biopharm-cancer-a35cbe9b</loc><lastmod>2026-11-05</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-05/bio-thera-gets-chinas-first-golimumab-biosimilar-approval-6f88eee8</loc><lastmod>2026-11-05</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-05/china-clears-yilings-pediatric-cold-granules-a-class-1-traditional-f3221584</loc><lastmod>2026-11-05</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-05/sinovents-funobactam-combination-matches-relebactam-regimen-in-hospital-7a2c3209</loc><lastmod>2026-11-05</lastmod></url>
  <url><loc>https://gosset.ai/news/2026-11-05/emergent-wins-up-to-22-3m-us-military-order-for-biothrax-anthrax-vaccine-18e1e9b8</loc><lastmod>2026-11-05</lastmod></url>
</urlset>
